tradingkey.logo

Bone Biologics Corp

BBLGW
Detailliertes Diagramm anzeigen
12.550USD
-6.240-33.21%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
0.00Marktkapitalisierung
--KGV TTM

Bone Biologics Corp

12.550
-6.240-33.21%
Intraday
1m
30m
1h
D
W
M
D

Heute

-33.21%

5 Tage

-20.32%

1 Monat

+3.29%

6 Monate

0.00%

Seit Jahresbeginn

-61.38%

1 Jahr

-86.13%

Detailliertes Diagramm anzeigen

TradingKey Aktien-Score

Kein Aktien-Score verfügbar aufgrund unzureichender Daten.

Bone Biologics Corp Nachrichten

Bald gibt es mehr Neuigkeiten, bleiben Sie dran...

Finanzindikatoren

EPS

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Gesamteinnahmen

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Bone Biologics Corp Informationen

Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
BörsenkürzelBBLGW
UnternehmenBone Biologics Corp
CEOMr. Jeffrey Frelick
Websitehttps://www.bonebiologics.com/
KeyAI